Jeffery Lange joins SciClone as VP of business development
This article was originally published in Scrip
Executive Summary
SciClone Pharmaceuticals (US) has named Jeffery Lange vice-president of business development. In this position, he will lead business development activities for SciClone's pipeline of product candidates in viral infectious diseases and oncology, as well as its business in China. Mr Lange most recently served as director of business development and licensing finance at Novartis.